Core Therapeutic Protocol for Disc Degeneration Disease
The foundation of our approach involves the precise intradiscal and peridiscal administration of
umbilical cord-derived mesenchymal stem cells (UC-MSCs). These cells are selected for their documented
immunomodulatory properties and potential to support extracellular matrix synthesis within the
intervertebral disc. Administration is performed under fluoroscopic guidance to ensure accurate
placement within or adjacent to the affected disc spaces.
Following cellular administration, patients engage in a structured rehabilitation program specifically
designed for spinal conditions. This program integrates progressive physical therapy protocols that
balance protection of the treated segments with gradual restoration of spinal mobility, core stability,
and functional movement patterns. The rehabilitation component is individually calibrated based on the
extent of disc degeneration, spinal segment involvement, and the patient's functional baseline.